Deals in brief: Singapore-based ChemT, Synvo, and H3 Zoom raise funding; 100x100 launches climate fund; seven China investments; and more

ChemT raises USD 5 million for AI-powered biomanufacturing

ChemT Biotechnology, a Singapore-based biotechnology company, has raised USD 5 million over 18 months, comprising USD 1 million in angel investment and a USD 4 million seed round. The seed round was led by Wavemaker Ventures, with participation from Seeds Capital, Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator.

The company is building an intelligence layer for biomanufacturing through CelMo, its artificial intelligence-driven virtual cell platform trained on proprietary biological sequencing data and validated in the lab.

ChemT will use the financing to expand its AI and experimental infrastructure, with the goal of making advanced medicines easier to manufacture, scale, and deliver.

Jie Sun (left) and Ling Wu, co-founders of ChemT Biotechnology. Photo courtesy of the company.